{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:42:02Z","timestamp":1792089722334,"version":"4.4.0"},"reference-count":78,"publisher":"The Endocrine Society","issue":"12","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":1,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL12002"],"award-info":[{"award-number":["HL12002"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["HL120760"],"award-info":[{"award-number":["HL120760"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HD098872"],"award-info":[{"award-number":["HD098872"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"name":"DRC at Washington University","award":["P30 DK020579"],"award-info":[{"award-number":["P30 DK020579"]}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR000448"],"award-info":[{"award-number":["UL1TR000448"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009340","name":"Children's Discovery Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001833","name":"Saigh Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Insulin-mediated pseudoacromegaly (IMPA) is a rare disease of unknown etiology. Here we report a 12-year-old female with acanthosis nigricans, hirsutism, and acromegalic features characteristic of IMPA. The subject was noted to have normal growth hormone secretion, with extremely elevated insulin levels. Studies were undertaken to determine a potential genetic etiology for IMPA. The proband and her family members underwent whole exome sequencing. Functional studies were undertaken to validate the pathogenicity of candidate variant alleles. Whole exome sequencing identified monoallelic, predicted deleterious variants in genes that mediate fibroblast growth factor 21 (FGF21) signaling, FGFR1 and KLB, which were inherited in trans from each parent. FGF21 has multiple metabolic functions but no known role in human insulin resistance syndromes. Analysis of the function of the FGFR1 and KLB variants in vitro showed greatly attenuated ERK phosphorylation in response to FGF21, but not FGF2, suggesting that these variants act synergistically to inhibit endocrine FGF21 signaling but not canonical FGF2 signaling. Therefore, digenic variants in FGFR1 and KLB provide a potential explanation for the subject\u2019s severe insulin resistance and may represent a novel category of insulin resistance syndromes related to FGF21.<\/jats:p>","DOI":"10.1210\/jendso\/bvaa138","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T23:56:24Z","timestamp":1600818984000},"source":"Crossref","is-referenced-by-count":10,"title":["Digenic Variants in the FGF21 Signaling Pathway Associated with Severe Insulin Resistance and Pseudoacromegaly"],"prefix":"10.1210","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-9341","authenticated-orcid":false,"given":"Stephen I","family":"Stone","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Endocrinology & Diabetes, Washington University School of Medicine, St. Louis, Missouri, US"},{"name":"Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1625-2830","authenticated-orcid":false,"given":"Daniel J","family":"Wegner","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis, Missouri, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9299-0499","authenticated-orcid":false,"given":"Jennifer A","family":"Wambach","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis, Missouri, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3797-9369","authenticated-orcid":false,"given":"F Sessions","family":"Cole","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Newborn Medicine, Washington University School of Medicine, St. Louis, Missouri, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9944-6293","authenticated-orcid":false,"given":"Fumihiko","family":"Urano","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri, US"},{"name":"Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, US"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1592-7629","authenticated-orcid":false,"given":"David M","family":"Ornitz","sequence":"additional","affiliation":[{"name":"Department of Developmental Biology, Washington University School of Medicine, St. Louis, Missouri, US"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"issue":"3","key":"2020120503065984100_CIT0001","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/ajcp\/26.3.283","article-title":"Familial hypertrophy of pineal body, hyperplasia of adrenal cortex and diabetes mellitus; report of 3 cases","volume":"26","author":"Rabson","year":"1956","journal-title":"Am J Clin Pathol."},{"issue":"3","key":"2020120503065984100_CIT0002","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1210\/jcem-48-3-495","article-title":"Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation","volume":"48","author":"D\u2019Ercole","year":"1979","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020120503065984100_CIT0003","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0029-1212090","article-title":"Insulin-mediated pseudoacromegaly in a patient with severe insulin resistance: association of defective insulin-stimulated glucose transport with impaired phosphatidylinositol 3-kinase activity in fibroblasts","volume":"107","author":"Kausch","year":"1999","journal-title":"Exp Clin Endocrinol Diabetes."},{"issue":"10","key":"2020120503065984100_CIT0004","first-page":"3465","article-title":"Severe insulin resistance, diabetes mellitus, hypertriglyceridemia, and pseudoacromegaly","volume":"81","author":"Kumar","year":"1996","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2020120503065984100_CIT0005","doi-asserted-by":"crossref","first-page":"156","DOI":"10.14310\/horm.2002.1306","article-title":"Insulin-mediated \u201cpseudoacromegaly\u201d","volume":"10","author":"Sam","year":"2011","journal-title":"Hormones (Athens)."},{"issue":"5","key":"2020120503065984100_CIT0006","first-page":"12","article-title":"Insulin-mediated pseudoacromegaly: a case report and review of the literature","volume":"104","author":"Yaqub","year":"2008","journal-title":"W V Med J."},{"issue":"4","key":"2020120503065984100_CIT0007","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/adc.88.4.332","article-title":"Hyperinsulinism and overgrowth without obesity","volume":"88","author":"Srinivasan","year":"2003","journal-title":"Arch Dis Child."},{"issue":"2","key":"2020120503065984100_CIT0008","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1515\/jpem-2017-0398","article-title":"Insulin-mediated pseudoacromegaly: a report of two pediatric patients","volume":"31","author":"Inman","year":"2018","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"2","key":"2020120503065984100_CIT0009","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.dsx.2018.12.009","article-title":"Insulin resistance and pseudoacromegaly: a case report","volume":"13","author":"Moradi","year":"2019","journal-title":"Diabetes Metab Syndr."},{"issue":"6","key":"2020120503065984100_CIT0010","first-page":"1533","article-title":"Insulin-mediated pseudoacromegaly: clinical and biochemical characterization of a syndrome of selective insulin resistance","volume":"76","author":"Flier","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2020120503065984100_CIT0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The fibroblast growth factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip Rev Dev Biol."},{"issue":"6","key":"2020120503065984100_CIT0012","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.cmet.2007.05.010","article-title":"FGF21: a missing link in the biology of fasting","volume":"5","author":"Reitman","year":"2007","journal-title":"Cell Metab."},{"issue":"12","key":"2020120503065984100_CIT0013","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1172\/JCI83349","article-title":"FGF21 and the late adaptive response to starvation in humans","volume":"125","author":"Fazeli","year":"2015","journal-title":"J Clin Invest."},{"issue":"2","key":"2020120503065984100_CIT0014","doi-asserted-by":"crossref","first-page":"e0148252","DOI":"10.1371\/journal.pone.0148252","article-title":"Fibroblast growth factor 21 (FGF21) protects against high fat diet induced inflammation and islet hyperplasia in pancreas","volume":"11","author":"Singhal","year":"2016","journal-title":"Plos One."},{"issue":"5","key":"2020120503065984100_CIT0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cmet.2017.09.005","article-title":"FGF19, FGF21, and an FGFR1\/\u03b2-Klotho-activating antibody act on the nervous system to regulate body weight and glycemia","volume":"26","author":"Lan","year":"2017","journal-title":"Cell Metab."},{"issue":"11","key":"2020120503065984100_CIT0016","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2337\/db10-0193","article-title":"Obesity is a fibroblast growth factor 21 (FGF21)-resistant state","volume":"59","author":"Fisher","year":"2010","journal-title":"Diabetes."},{"issue":"16","key":"2020120503065984100_CIT0017","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1093\/nar\/gkq603","article-title":"ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"7616","key":"2020120503065984100_CIT0018","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature."},{"key":"2020120503065984100_CIT0019","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"Karczewski","year":"2020","journal-title":"Nature."},{"issue":"3","key":"2020120503065984100_CIT0020","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet."},{"issue":"5","key":"2020120503065984100_CIT0021","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1101\/gr.176601","article-title":"Predicting deleterious amino acid substitutions","volume":"11","author":"Ng","year":"2001","journal-title":"Genome Res."},{"issue":"4","key":"2020120503065984100_CIT0022","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nmeth0410-248","article-title":"A method and server for predicting damaging missense mutations","volume":"7","author":"Adzhubei","year":"2010","journal-title":"Nat Methods."},{"issue":"9","key":"2020120503065984100_CIT0023","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gr.092619.109","article-title":"Identification of deleterious mutations within three human genomes","volume":"19","author":"Chun","year":"2009","journal-title":"Genome Res."},{"issue":"4","key":"2020120503065984100_CIT0024","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nmeth.2890","article-title":"MutationTaster2: mutation prediction for the deep-sequencing age","volume":"11","author":"Schwarz","year":"2014","journal-title":"Nat Methods."},{"issue":"12","key":"2020120503065984100_CIT0025","doi-asserted-by":"crossref","first-page":"e1001025","DOI":"10.1371\/journal.pcbi.1001025","article-title":"Identifying a high fraction of the human genome to be under selective constraint using GERP++","volume":"6","author":"Davydov","year":"2010","journal-title":"Plos Comput Biol."},{"issue":"7","key":"2020120503065984100_CIT0026","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1101\/gr.3577405","article-title":"Distribution and intensity of constraint in mammalian genomic sequence","volume":"15","author":"Cooper","year":"2005","journal-title":"Genome Res."},{"issue":"2 Pt 1","key":"2020120503065984100_CIT0027","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1288\/00005537-198402000-00004","article-title":"University of Pennsylvania Smell Identification Test: a rapid quantitative olfactory function test for the clinic","volume":"94","author":"Doty","year":"1984","journal-title":"Laryngoscope."},{"key":"2020120503065984100_CIT0028","doi-asserted-by":"crossref","first-page":"16273","DOI":"10.1038\/srep16273","article-title":"2A self-cleaving peptide-based multi-gene expression system in the silkworm Bombyx mori","volume":"5","author":"Wang","year":"2015","journal-title":"Sci Rep."},{"key":"2020120503065984100_CIT0029","article-title":"Supplementary materials for digenic variants in the FGF21 signaling pathway associated with severe insulin resistance and pseudoacromegaly","author":"Stone","year":"2020"},{"issue":"10","key":"2020120503065984100_CIT0030","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.4158\/EP15698.OR","article-title":"The effect of phlebotomy-induced hemolysis on insulin level determination","volume":"21","author":"Zornitzki","year":"2015","journal-title":"Endocr Pract."},{"issue":"9","key":"2020120503065984100_CIT0031","first-page":"2849","article-title":"Serum leptin levels in normal children: relationship to age, gender, body mass index, pituitary-gonadal hormones, and pubertal stage","volume":"82","author":"Garcia-Mayor","year":"1997","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2020120503065984100_CIT0032","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1210\/jc.2002-022033","article-title":"Adiponectin levels in women with polycystic ovary syndrome","volume":"88","author":"Orio","year":"2003","journal-title":"J Clin Endocrinol Metab."},{"issue":"43","key":"2020120503065984100_CIT0033","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"2020120503065984100_CIT0034","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.tem.2010.11.003","article-title":"FGF21 reloaded: challenges of a rapidly growing field","volume":"22","author":"Kharitonenkov","year":"2011","journal-title":"Trends Endocrinol Metab."},{"issue":"6","key":"2020120503065984100_CIT0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/ajcp\/47.6.709","article-title":"Insulin response in glucose-tolerance tests","volume":"47","author":"Burrows","year":"1967","journal-title":"Am J Clin Pathol."},{"issue":"2","key":"2020120503065984100_CIT0036","first-page":"77","article-title":"Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals","volume":"2","author":"Hanks","year":"2015","journal-title":"J Clin Transl Endocrinol."},{"issue":"4","key":"2020120503065984100_CIT0037","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/cen.12552","article-title":"Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females","volume":"82","author":"Hanks","year":"2015","journal-title":"Clin Endocrinol (Oxf)."},{"key":"2020120503065984100_CIT0038","first-page":"1379","article-title":"KLB, encoding \u03b2-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism","volume-title":"EMBO Mol Med","author":"Xu","year":"2017"},{"key":"2020120503065984100_CIT0039","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.mce.2006.04.021","article-title":"Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes","volume":"254-255","author":"Pitteloud","year":"2006","journal-title":"Mol Cell Endocrinol."},{"issue":"5","key":"2020120503065984100_CIT0040","doi-asserted-by":"crossref","first-page":"e38438","DOI":"10.1371\/journal.pone.0038438","article-title":"Fundamentals of FGF19 & FGF21 action in vitro and in vivo","volume":"7","author":"Adams","year":"2012","journal-title":"Plos One."},{"issue":"7","key":"2020120503065984100_CIT0041","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1083\/jcb.200903030","article-title":"The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking","volume":"187","author":"Francavilla","year":"2009","journal-title":"J Cell Biol."},{"issue":"24","key":"2020120503065984100_CIT0042","doi-asserted-by":"crossref","first-page":"19997","DOI":"10.1074\/jbc.M111.325670","article-title":"Dynamics and distribution of Klotho\u03b2 (KLB) and fibroblast growth factor receptor-1 (FGFR1) in living cells reveal the fibroblast growth factor-21 (FGF21)-induced receptor complex","volume":"287","author":"Ming","year":"2012","journal-title":"J Biol Chem."},{"issue":"2","key":"2020120503065984100_CIT0043","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"G\u00e4lman","year":"2008","journal-title":"Cell Metab."},{"key":"2020120503065984100_CIT0044","first-page":"193","article-title":"Insulin resistance: the clinical spectrum","volume":"6","author":"Mantzoros","year":"1995","journal-title":"Adv Endocrinol Metab."},{"issue":"6","key":"2020120503065984100_CIT0045","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1210\/jcem-50-6-1139","article-title":"Demonstration of a primary (? genetic) defect in insulin receptors in fibroblasts from a patient with the syndrome of insulin resistance and acanthosis nigricans type A","volume":"50","author":"Kahn","year":"1980","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2020120503065984100_CIT0046","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0002-9378(83)90091-1","article-title":"Hyperandrogenism, insulin resistance, and acanthosis nigricans syndrome: a common endocrinopathy with distinct pathophysiologic features","volume":"147","author":"Barbieri","year":"1983","journal-title":"Am J Obstet Gynecol."},{"issue":"12","key":"2020120503065984100_CIT0047","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1056\/NEJMoa022050","article-title":"Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene","volume":"348","author":"Farooqi","year":"2003","journal-title":"N Engl J Med."},{"issue":"2","key":"2020120503065984100_CIT0048","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet."},{"issue":"6636","key":"2020120503065984100_CIT0049","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature."},{"issue":"6674","key":"2020120503065984100_CIT0050","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Cl\u00e9ment","year":"1998","journal-title":"Nature."},{"issue":"10","key":"2020120503065984100_CIT0051","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1136\/jmg.39.10.722","article-title":"Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy","volume":"39","author":"Van Maldergem","year":"2002","journal-title":"J Med Genet."},{"issue":"1","key":"2020120503065984100_CIT0052","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/qjmed\/90.1.27","article-title":"Dunnigan-Kobberling syndrome: an autosomal dominant form of partial lipodystrophy","volume":"90","author":"Jackson","year":"1997","journal-title":"Qjm."},{"issue":"3","key":"2020120503065984100_CIT0053","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1172\/JCI28003","article-title":"PPAR gamma and human metabolic disease","volume":"116","author":"Semple","year":"2006","journal-title":"J Clin Invest."},{"issue":"5","key":"2020120503065984100_CIT0054","first-page":"1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety)","volume":"85","author":"Garg","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"key":"2020120503065984100_CIT0055","article-title":"Pseudoacromegaly in congenital generalised lipodystrophy (Berardinelli-Seip syndrome)","volume":"2016","author":"Chakraborty","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"8","key":"2020120503065984100_CIT0056","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1210\/js.2017-00164","article-title":"Pseudoacromegaly: a differential diagnostic problem for acromegaly with a genetic solution","volume":"1","author":"Dahlqvist","year":"2017","journal-title":"J Endocr Soc."},{"issue":"5","key":"2020120503065984100_CIT0057","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes."},{"issue":"5","key":"2020120503065984100_CIT0058","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2017-00016","article-title":"Fibroblast growth factor 21-metabolic role in mice and men","volume":"38","author":"Staiger","year":"2017","journal-title":"Endocr Rev."},{"issue":"9","key":"2020120503065984100_CIT0059","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1210\/en.2009-0221","article-title":"Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity","volume":"150","author":"Berglund","year":"2009","journal-title":"Endocrinology."},{"issue":"5","key":"2020120503065984100_CIT0060","doi-asserted-by":"crossref","first-page":"E1105","DOI":"10.1152\/ajpendo.00348.2009","article-title":"Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models\u2013association with liver and adipose tissue effects","volume":"297","author":"Xu","year":"2009","journal-title":"Am J Physiol Endocrinol Metab."},{"issue":"6","key":"2020120503065984100_CIT0061","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J Clin Invest."},{"issue":"4","key":"2020120503065984100_CIT0062","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrm782","article-title":"Regulated transport of the glucose transporter GLUT4","volume":"3","author":"Bryant","year":"2002","journal-title":"Nat Rev Mol Cell Biol."},{"issue":"5","key":"2020120503065984100_CIT0063","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/bcp.12676","article-title":"Pharmacokinetics and pharmacodynamics of PF-05231023, a novel long-acting FGF21 mimetic, in a first-in-human study","volume":"80","author":"Dong","year":"2015","journal-title":"Br J Clin Pharmacol."},{"issue":"3","key":"2020120503065984100_CIT0064","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cmet.2013.08.005","article-title":"The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes","volume":"18","author":"Gaich","year":"2013","journal-title":"Cell Metab."},{"issue":"1","key":"2020120503065984100_CIT0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.cmet.2008.05.006","article-title":"Inhibition of growth hormone signaling by the fasting-induced hormone FGF21","volume":"8","author":"Inagaki","year":"2008","journal-title":"Cell Metab."},{"issue":"1","key":"2020120503065984100_CIT0066","first-page":"408","article-title":"A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab."},{"issue":"6764","key":"2020120503065984100_CIT0067","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/47254","article-title":"Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension","volume":"402","author":"Barroso","year":"1999","journal-title":"Nature."},{"issue":"10","key":"2020120503065984100_CIT0068","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJM198903093201005","article-title":"Specificity spillover at the hormone receptor\u2013exploring its role in human disease","volume":"320","author":"Fradkin","year":"1989","journal-title":"N Engl J Med."},{"issue":"36","key":"2020120503065984100_CIT0069","doi-asserted-by":"crossref","first-page":"25869","DOI":"10.1074\/jbc.M605189200","article-title":"Hybrid receptors formed by insulin receptor (IR) and insulin-like growth factor I receptor (IGF-IR) have low insulin and high IGF-1 affinity irrespective of the IR splice variant","volume":"281","author":"Slaaby","year":"2006","journal-title":"J Biol Chem."},{"issue":"10","key":"2020120503065984100_CIT0070","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.15252\/emmm.201607376","article-title":"KLB, encoding \u03b2-Klotho, is mutated in patients with congenital hypogonadotropic hypogonadism","volume":"9","author":"Xu","year":"2017","journal-title":"EMBO Mol Med."},{"issue":"4","key":"2020120503065984100_CIT0071","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1747-0285.2012.01325.x","article-title":"Understanding the physical interactions in the FGF21\/FGFR\/\u03b2-Klotho complex: structural requirements and implications in FGF21 signaling","volume":"79","author":"Yie","year":"2012","journal-title":"Chem Biol Drug Des."},{"issue":"7689","key":"2020120503065984100_CIT0072","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/nature25010","article-title":"Structures of \u03b2-klotho reveal a \u2018zip code\u2019-like mechanism for endocrine FGF signalling","volume":"553","author":"Lee","year":"2018","journal-title":"Nature."},{"issue":"10","key":"2020120503065984100_CIT0073","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tibs.2006.08.004","article-title":"The surprising complexity of signal sequences","volume":"31","author":"Hegde","year":"2006","journal-title":"Trends Biochem Sci."},{"issue":"1-2","key":"2020120503065984100_CIT0074","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/mgme.2000.3066","article-title":"Synergistic heterozygosity: disease resulting from multiple partial defects in one or more metabolic pathways","volume":"71","author":"Vockley","year":"2000","journal-title":"Mol Genet Metab."},{"issue":"3","key":"2020120503065984100_CIT0075","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/cge.13150","article-title":"Digenic inheritance and genetic modifiers","volume":"93","author":"Deltas","year":"2018","journal-title":"Clin Genet."},{"issue":"4","key":"2020120503065984100_CIT0076","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/ng926","article-title":"Digenic inheritance of severe insulin resistance in a human pedigree","volume":"31","author":"Savage","year":"2002","journal-title":"Nat Genet."},{"issue":"7","key":"2020120503065984100_CIT0077","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1248\/bpb.34.1120","article-title":"Thiazolidinediones are potent inducers of fibroblast growth factor 21 expression in the liver","volume":"34","author":"Oishi","year":"2011","journal-title":"Biol Pharm Bull."},{"issue":"6","key":"2020120503065984100_CIT0078","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.tem.2014.03.001","article-title":"FGF21-based pharmacotherapy\u2013potential utility for metabolic disorders","volume":"25","author":"Gimeno","year":"2014","journal-title":"Trends Endocrinol Metab."}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvaa138\/33781301\/bvaa138.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/4\/12\/bvaa138\/34713869\/bvaa138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jes\/article-pdf\/4\/12\/bvaa138\/34713869\/bvaa138.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,5]],"date-time":"2020-12-05T08:09:06Z","timestamp":1607155746000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvaa138\/5910104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":78,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvaa138","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12]]},"published":{"date-parts":[[2020,9,22]]},"article-number":"bvaa138"}}